AVTX - Avalo Therapeutics GAAP EPS of -$0.11 beats by $0.99 revenue of $0.24M misses by $0.76M
2023-11-09 07:46:12 ET
More on Avalo Therapeutics
- Avalo enters agreement to divest AVTX-800 series
- Seeking Alpha’s Quant Rating on Avalo Therapeutics
- Historical earnings data for Avalo Therapeutics
- Financial information for Avalo Therapeutics
For further details see:
Avalo Therapeutics GAAP EPS of -$0.11 beats by $0.99, revenue of $0.24M misses by $0.76M